Steve SchoonoogheJannick LeœnJurgen Haustraete
New antibody derivatives are continuously being generated to interact with a range of therapeutic targets. The cost-effective and efficient production of these and other antibody derivatives is crucial for their further success. Here, we describe the construction of the expression vectors needed for heterologous expression of a Fab fragment in the yeast Pichia pastoris. The experimental conditions for lab-scale expressions are discussed, and an overview of an efficient purification strategy is presented.
Koichi AndōPatthra ArunwanichKenichi KaiMasashige ShinkaiHiroyuki HondaTakeshi Kobayashi
A. V. KozyrТ. В. БобикA. N. IgnatovaA. V. Kolesnikov
Sheldon J.B. DuffWilliam D. Murray